Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “EMT”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 181 records · Page 10
All sourcesNASA NTRSDOE OSTI
DOE OSTI2024

A Semi-Analytical Approach for State-Space Electromagnetic Transient Simulation

Here, this paper proposes a semi-analytical approach for efficient and accurate electromagnetic transient (EMT) simulation of a power grid. The approach first derives a high-order semi-analytical solution (SAS) of the grid’s state-space EMT model using the differential transformation (DT), and then evaluates the solution over enlarged, variable time steps to significantly accelerate the simulations while maintaining its high accuracy on detailed fast EMT dynamics. The approach also addresses switches during large time steps by using a limit violation detection algorithm with a binary search-enhanced quadratic interpolation. Case studies are conducted on EMT models of the IEEE 39-bus system and large-scale systems to demonstrate the merits of the new simulation approach against traditional numerical methods.

electromagnetic transient↗
DOE OSTI2024

Linear Solvers for Collector Systems of Generalized Large-scale Inverter-Based Resources

Collector systems for inverter-based resources (IBRs) are typically represented by equivalent circuits for electromagnetic transient (EMT) simulations. Recent studies have revealed that modeling a detailed collector system is essential to accurately represent the behavior of IBRs, especially when dealing with partial tripping during external disturbances. However, there are several challenges in simulating a detailed EMT model of a collector system due to the time required to simulate such systems. Thus, this paper investigates the modeling of a detailed collector system, taking into account its configuration and components as defined in IEEE standard 2800. The configurations include the collector systems of generalized large-scale IBR plants. The components include the main IBR transformer, collector bus, and feeders with lines and/or cables. The EMT model of the collector system is represented by differential algebraic equations (DAEs) that are discretized to form linear equations that are solved using linear solvers. In this paper, linear solvers are proposed based on the Schur complement method, which are utilized for simulation of the EMT model of collector systems of generalized large-scale IBRs to accelerate simulation speed while maintaining the accuracy of the results. The proposed solvers are verified by comparing the performance to that of linear solvers provided in MATLAB.

Choi, Jongchan↗
DOE OSTI2015

SU-F-BRA-02: Electromagnetic Tracking in Brachytherapy as An Advanced Modality for Treatment Quality Assurance

Purpose: To present the use of Electromagnetic Tracking (EMT) for quality assurance in brachytherapy by means of phantom studies and to assess the clinical applicability of EMT during HDR breast brachytherapy. Methods: An EMT system was investigated to examine its suitability for clinical applications in brachytherapy. A field generator served as electromagnetic field emitter. Sensors (magnetic sensitive only), connected to a control unit, were used and their respective position and orientation inside a pre-defined measurement volume (500 mm cube length) determined. Up to three 6DoF sensors were placed on the phantom’s surface to obtain additional reference coordinates used to derive relative measured positions of a smaller 5DoF sensor inserted in the 6F catheters of the implant. The catheters were successively measured by manual displacement of the sensor at ∼40 mm/s. The measured catheter tracks, acquired multiple times at various locations (CT and treatment room), were smoothed, divided into intervals (2.5 mm dwell step size), registered (rigid Iterative Closest Point transformation) and compared against the known phantom geometry. Results: The reference coordinates were used to exclude the influence of external (e.g., respiratory-induced) motion. Precision tests in a clinical setting showed variances below 1 mm (translational) and 1° (rotational), respectively. Our method for catheter reconstruction preserved the length of the tracked catheter (within 1 mm). The measured tracking accuracy was 1±0.3 mm (maximum: 2 mm). The results are less accurate in environments potentially interfering with the magnetic field, e.g., in the vicinity of ferromagnetic table components. Conclusion: Our EMT system is able to perform reproducible and accurate catheter tracking and reconstruction. Currently, measurements of the implant geometry in HDR breast treatments are initiated. Online implant monitoring by means of EM tracking may be a first step towards advanced brachytherapy treatment QA. The study was financially supported by ELEKTA | Nucletron. There are no further disclosures and conflicts.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2019

Environmental Assessment for Use of DOE-Owned High-Assay Low-Enriched Uranium Stored at Idaho National Laboratory

The U.S. Department of Energy (DOE) proposes to make available about 10 Metric Tons (MT) of High-Assay Low-Enriched Uranium (HALEU ) feedstock produced through the electrometallurgical treatment (EMT) process, and other small quantities of HALEU stored at Idaho National Laboratory (INL) for research development & demonstration in support of the commercial nuclear industry and government agencies, including use in advanced reactors. HALEU is a term applied to uranium that is enriched in the uranium-235 (U-235) isotope to a value that is 5% to 20% of the total uranium. Private sector advanced nuclear reactor designs and advanced nuclear fuel designs call for use of HALEU, but currently no commercial facility manufactures HALEU. DOE proposes to expand the fuel fabrication capability at INL to produce HALEU fuel at INL from 10 MT of HALEU feedstock to meet near-term needs. The production requires expansion of the fuel fabrication capability, including the purchase of new equipment and use of facilities at INL’s Materials and Fuels Complex (MFC) and the Idaho Nuclear Technology and Engineering Center (INTEC). DOE has made no decision on the specific use of the fuel. The fuel could be used in advanced reactor design or for the purpose of research and development. DOE would work with other Federal agencies and commercial vendors to determine use of HALEU fuel. Use of this HALEU, including its potential use in a future nuclear reactor, will be analyzed in future National Environmental Policy Act (NEPA) documents by the appropriate agency. The EMT process in operation at the INL converts sodium-bonded spent nuclear fuel into waste forms suitable for disposal as high-level waste and a HALEU product that is unsuitable for diversion to nuclear weapons but could be either reused in fuel or disposed of as waste. The Final Environmental Impact Statement for the Treatment and Management of Sodium-Bonded Spent Nuclear Fuel, DOE/EIS-0306, DOE 2000) discussed the EMT process, but did not make a decision on the disposition or use of the HALEU product from the EMT process. This Environmental Assessment (EA) addresses the HALEU product as HALEU feedstock in production of HALEU fuel.

99 GENERAL AND MISCELLANEOUS↗
DOE OSTI2019

Jiangsu Nanjing – Lawrence Berkeley Life Sciences Center for Translational Medicine (CRADA AWD00000392)

Project 1: Our previous work demonstrated that the CES biomarker can be an approximate measure for the levels of chromosomal instability (CIN) in cancer, and that the CES (for Centromere and kinetochore gene Expression Score) biomarker effectively predicts which cancer patients benefit from adjuvant chemotherapies in lung and other cancer types. Such a utility can potentially reduce overtreatment that is common in lung cancer treatment. We determined performance of the multiplex Quantigene RNA assay platform for measuring mRNA levels of CES genes using clinical tumor samples. These experiments determined sensitivity, specificity and detection limit of 12 CES genes and 5 control genes using clinical tumor samples with paired normal tissue samples. We determined how sample concentration and storage conditions affect measurement sensitivity and specificity, and whether sample storage over time affects result reproducibility. Importantly, we confirmed that early stage lung cancer CES values are significantly higher than those of paired normal tissues in all cases. This result greatly extended our bioinformatic data mining by confirming that we can measure CES values directly from patient tumor tissue, and that tumors have higher CES values than normal tissues. Unfortunately, our CRADA partner in China did not finish measuring CES expression levels for a larger group of ~100 tumor samples, due to the long period time required for human subject review in China. This delay prevented us from generating enough additional data to generate a significant statistical model. We finished analyzing all the data acquired during the CRADA, and are trying to work collaboratively with the Shanghai University Lung Cancer Hospital to complete the analysis of more tumor samples. Although no publications have resulted from this research, the findings are crucial for ongoing efforts to obtain funding to develop the technology to address problems in deciding on appropriate treatment regimens for individual patients, in clinical settings. Project 2: The overarching milestones of CRADA Project 2 were to investigate the role of FAM83 family members in cancer progression. Two publications resulted from this work which are highlighted below. The first major goal of the CRADA was to broadly assess the role of FAM83 family oncogenes in human cancer using a multi-omic bioinformatic approach (Snijders et al 2017 Mol. Oncol 11). The second major goal was to specifically assess the role of FAM83D in a cancer progression and metastasis (Yin et al 2019 Cell Oncol; in revision). Role of FAM83 family oncogenes in human cancers Recent studies from our laboratory as well as other groups have demonstrated that FAM83 family members have oncogenic properties and have significantly elevated expression levels in multiple human tumor types, including breast cancers (BC). We performed an integrative multi-omics bio-informatic analysis of the role of FAM83 family oncogenes in human cancers. Our findings were published in the journal Molecular Oncology (Snijders et al; Mol Oncol. 2017 Feb;11(2):167-179). Highlights from this manuscript are: • Transcriptional levels of FAM83 family members are frequently and dramatically elevated across tumor types in human • DNA copy number increase appears to be a potential mechanism for increased expression of FAM83 genes • FAM83 family gene signature is associated with poor survival across human tumor types • FAM83 gene alterations are significantly correlated with TP53, PIK3CA and Ecadherin mutations. In conclusion, this analysis of FAM83 family members opened up a new horizon for further understanding the significance of FAM83 genes in cancer and clinical applications in diagnosis, prognosis and therapy. Role of FAM83D in human non-small cell lung cancer (NSCLC) metastasis and its impact on chemotherapy. Lung cancer is one of the most common malignant tumors in the world and non-small cell lung cancer (NSCLC) accounts for 80~85% of all diagnosed lung cancer cases, one of the deadliest cancers worldwide. FAM83D has been proposed as an oncoprotein in several types of human cancer, yet its role and molecular mechanism in human non-small cell lung cancer (NSCLC) metastasis and its impact on chemotherapy are poorly understood. We evaluated the expression of FAM83D in NSCLC cells and cancerous tissues and its prognostic significance, then investigated the effect of FAM83D on tumorigenic phenotypes such as cell proliferation, EMT and invasive capability, and finally assessed impact of FAM83D on NSCLC chemo-drug resistance. The results of this study are currently in revision at the journal Cellular Oncology. Highlights from this manuscript are: • FAM83D expression is elevated in NSCLC cells and tissues and associated with poor prognosis • FAM83D promotes NSCLC cell proliferation • FAM83D induces EMT in NSCLC cells • FAM83D promotes NSCLC cell migration and invasion • FAM83D promotes EMT and invasive capability of NSCLC cells by regulating AKT/mTOR pathway • FAM83D silencing increases cisplatin sensitivity of NSCLC cells In summary, this second study demonstrated for the first time that FAM83D promoted EMT and metastasis of NSCLC cells through AKT/mTOR signal pathway as well as increased the sensitivity of NSCLC to cisplatin. This study may provide potential targets for advanced NSCLC treatment and personalized therapy.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2023

Multi-Timescale Integrated Dynamics and Scheduling for Solar (MIDAS-Solar) (Final Technical Report)

Solar photovoltaic (PV) installations have experienced unprecedented growth in the United States. PV will become not only an energy producer but also a necessary provider of ancillary services at multiple timescales. Conventional methods to simulate power systems operations - such as long-term production simulation (which typically considers schedules from hours to minutes by using an optimization framework) and short-term transient studies (which simulate dynamics from seconds to sub-seconds using state variables and differential equations) - are not sufficient for studying the multiple-timescale variation of solar generation and its impact on system reliability. Long-term system economics and short-term system dynamics are highly coupled, particularly when the penetration level of renewable generation is extremely high, because the uncertainty and variability of solar generation will impact both power system steady-state and dynamic performance. This project helps meet and exceed the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Solar Energy Technologies Office goal of systems integration by directly addressing this stability and reliability challenge for power grid planning and operation. We have developed a temporally comprehensive, closed-loop simulation model, named Multi-timescale Integrated Dynamics and Scheduling (MIDAS), that seamlessly simulates power system operations from economic scheduling (day-ahead to hours) to dynamic response analysis (seconds to sub-seconds). For schedules with very high levels of inverter-based resources (IBRs), up to and including 100%, the stability of grid controls has been evaluated through electromagnetic transient (EMT) simulations and power-hardware-in-the-loop (PHIL) simulations of key transient events at key schedule points. Specifically, MIDAS provides: 1) a closed-loop simulation framework for simulating timescales from economic scheduling to dynamic stability analysis; 2) machine learning-based stability assessment; 3) EMT modeling and analysis for large-scale power systems; 4) MIDAS PHIL test bed. We worked with Hawaii Electric Companies to apply the MIDAS study framework to a Maui grid study. The entire island's transmission system was modeled in detail - from a yearly scheduling model, to a second-level frequency dynamic model, down to a sub-second-scale EMT model to address critical stability issues. The project demonstrated how MIDAS can help system planners and operators assess system reliability and stability while the power grid is marching toward a high-renewable, high-IBR future. In this Maui grid study, we found that 100% instantaneous IBR operation is achievable in EMT simulation and PHIL testing, and grid planners and operators might need new analysis/simulation tools to assess grid reliability and stability in the scheduling stage. MIDAS will bring Maui and other systems closer to 100% clean and stable energy futures. (In this study, we examined transient stability. Other topics necessary for 100% IBR operation, such as protection and resource adequacy, were not examined.)

100% Renewables↗
DOE OSTI2014

LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis

Transcriptional elongation by RNA polymerase (Pol) II is essential for gene expression during cell growth and differentiation. The positive transcription elongation factor b (P-TEFb) stimulates transcriptional elongation by phosphorylating Pol II and antagonizing negative elongation factors. A reservoir of P-TEFb is sequestered in the inactive 7SK snRNP where 7SK snRNA and the La-related protein LARP7 are required for the integrity of this complex. Here, we show that P-TEFb activity is important for the epithelial–mesenchymal transition (EMT) and breast cancer progression. Decreased levels of LARP7 and 7SK snRNA redistribute P-TEFb to the transcriptionally active super elongation complex, resulting in P-TEFb activation and increased transcription of EMT transcription factors, including Slug, FOXC2, ZEB2, and Twist1, to promote breast cancer EMT, invasion, and metastasis. Our data provide the first demonstration that the transcription elongation machinery plays a key role in promoting breast cancer progression by directly controlling the expression of upstream EMT regulators.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2023

An Electromagnetic Transient and Three-Phase Phasor Co-Simulation Platform for Studying Distribution System Transients with High Pentration of DERs

Inverter vendors usually have electro-magnetic transient (EMT) models of distributed energy resources (DERs) for validation purposes and these types of models are usually black-boxed considering intellectual property (IP) protection. Limited by small simulation time step for the entire power system network, studying the system-level responses of DERs in EMT simulators is more time-consuming as the network size increases. Meanwhile, vendors usually do not have inverter models that can be used in three-phase phasor-domain simulators. This paper proposes a platform that can dynamically co-simulate the EMT inverter models and three-phase phasor-domain distribution networks considering high penetration of inverter-based DERs. This platform is very useful for evaluating the impacts of vendor-provided black-box DER model on distribution system dynamics. The co-simulation platform is validated against the full EMT model using a simple two-inverter test system and tested using IEEE 34-node test feeder.

Liu, Yuan↗
DOE OSTI2020

Improving the Performance of Integrated Power-Hardware-in-the-Loop and Quasi-Static Time-Series Simulations

This paper introduces a novel multirate cosimulation architecture that overcomes previous challenges integrating faster real-time, microseconds-scale, power-hardware-in-the-loop (PHIL) with larger scale but slower, real-time, seconds-scale, quasi-static time-series (QSTS) simulation. Specifically, an intermediate reduced-equivalent electromagnetic transient (EMT) model duplicates the key power system topology to capture high-speed dynamics and converge hardware-power system interactions between QSTS updates. Exchanging multidimensional parameter vectors (loads, control status, etc.) between the QSTS and EMT models enables capturing the interactions of the rich, high-node-count (thousands of electrical nodes) QSTS model with the hardware. This architecture offers full spatial resolution from QSTS, including individual load dynamics, actual distribution management system controls, and nodal voltages. Simultaneously, the intermediate EMT model provides more detailed high-speed transients of key distributed energy resource hardware interactions. In addition, we use careful PHIL interface design and the exchange of complex power data, rather than current, to further improve performance. This cosimulation architecture is demonstrated by testing a simulated distribution system with an interconnected 500-kVA advanced photovoltaic (PV) inverter in PHIL. In conclusion, the architecture successfully captured PV local volt-volt ampere reactive (volt-VAR) control interactions with the larger network under time-varying electrical and weather conditions.

42 ENGINEERING↗
DOE OSTI2026

Electromagnetic Transient Modeling of Data Centers

This report serves as a user manual for the accompanying EMT model library developed by the National Laboratory of the Rockies (NLR) for various equipment in large data centers. The EMT model library enables detailed modeling of large data center loads for conducting grid stability studies. The EMT model library for data centers include detailed models of a 5.5 kW power supply unit (PSU), a 2.5 uninterruptible power supply (UPS), a 260 MW gas turbine-generator, a 500 kW motor load, and a 33 kW IT rack. These components represent all major equipment in data centers that need to be modeled for performing grid stability studies for data centers.

24 POWER TRANSMISSION AND DISTRIBUTION↗
DOE OSTI2015

Predicting the permeability of sediments entering subduction zones

Abstract Using end‐member permeabilities defined by a worldwide compilation of sediment permeabilities at convergent margins, we compare permeability predictions using a geometric mean and a two‐component effective medium theory (EMT). Our implementation of EMT includes a threshold fraction of the high‐permeability component that determines whether flow occurs dominantly in the high‐ or low‐permeability component. We find that this threshold fraction in most cases is equal to the silt + sand‐sized fraction of the sediment. This suggests that sediments undergoing primary consolidation tend to exhibit flow equally distributed between the high‐ and low‐permeability components. We show that the EMT method predicts permeability better than the weighted geometric mean of the end‐member values for clay fractions <0.6. This work provides insight into the microstructural controls on permeability in subducting sediments and valuable guidance for locations which lack site‐specific permeability results but have available grain‐size information.

Daigle, Hugh↗
DOE OSTI2014

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma

Highlights: • FGFR4 is significantly related with N stage in IHCC, with T stage and TNM stage in PHCC. • FGFR4 is an independent prognostic factor in IHCC and PHCC. • FGFR4 promotes proliferation, invasion and EMT in cholangiocarinoma cell lines. • Inhibitor AP24354 can decrease proliferation, invasion and induce apoptosis of CCA. - Abstract: Fibroblast growth factor receptor 4 (FGFR4) is related to poor prognosis of several cancers, but the correlation between FGFR4 expression and cholangiocarcinoma (CCA) has not been well elucidated. We investigated the expression of FGFR4 in 83 intrahepatic cholangiocarcinomas (IHCCs), 75 perihilar cholangiocarcinomas (PHCCs) and 41 distal cholangiocarcinomas (DCCs) by immunohistochemistry (IHC), and subsequently evaluated association of FGFR4 with clinicopathologic parameters and survival rate. The rate of FGFR4 higher expression was 61.4% (51/83) in IHCCs, 53.3% (40/75) in PHCCs and 56.1% (23/41) in DCCs. FGFR4 expression was significantly related to poor prognosis of IHCC (P = 0.002) and PHCC (P = 0.019) with univariate analysis, and also identified as an independent prognostic factor in IHCC (P = 0.045) and PHCC (P = 0.049) with multivariate analysis. Additionally, with functional assays in vitro, we found FGFR4 can induce proliferation, invasion and epithelial–mesenchymal transition (EMT) of CCA cell lines with FGF19 stimulation. Moreover, FGFR4 inhibitor AP24354 can suppress proliferation, invasion and induce apoptosis of CCA cells. In conclusion, FGFR4 expression can be identified as a significant independent prognostic biomarker of IHCC and PHCC. FGFR4 played a pivotal role in proliferation, invasion and EMT of CCA. FGFR4 inhibitor can suppress proliferation, invasion and induce apoptosis of CCA, indicating that FGFR4 may act as a potential therapeutic target.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2014

Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1

Highlights: • Depletion of Sox5 inhibits breast cancer proliferation, migration, and invasion. • Sox5 transactivates Twist1 expression. • Sox5 induces epithelial to mesenchymal transition through transactivation of Twist1 expression. - Abstract: The epithelial to mesenchymal transition (EMT), a highly conserved cellular program, plays an important role in normal embryogenesis and cancer metastasis. Twist1, a master regulator of embryonic morphogenesis, is overexpressed in breast cancer and contributes to metastasis by promoting EMT. In exploring the mechanism underlying the increased Twist1 in breast cancer cells, we found that the transcription factor SRY (sex-determining region Y)-box 5(Sox5) is up-regulation in breast cancer cells and depletion of Sox5 inhibits breast cancer cell proliferation, migration, and invasion. Furthermore, depletion of Sox5 in breast cancer cells caused a dramatic decrease in Twist1 and chromosome immunoprecipitation assay showed that Sox5 can bind directly to the Twist1 promoter, suggesting that Sox5 transactivates Twist1 expression. We further demonstrated that knockdown of Sox5 up-regulated epithelial phenotype cell biomarker (E-cadherin) and down-regulated mesenchymal phenotype cell biomarkers (N-cadherin, Vimentin, and Fibronectin 1), resulting in suppression of EMT. Our study suggests that Sox5 transactivates Twist1 expression and plays an important role in the regulation of breast cancer progression.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2014

Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases γ-radiation-induced sensitivity in some pancreatic cancer cell lines

Highlights: • FBLN-3 gene was poorly expressed in some pancreatic cancer lines. • FBLN-3 promoter region was highly methylated in some pancreatic cancer cell lines. • FBLN-3 inhibited c-MET activation and expression and reduced cellular level of ALDH1. • FBLN-3/c-Met/ALDH1 axis modulates stemness and EMT in pancreatic cancer cells. - Abstract: Fibulin-3 (FBLN-3) has been postulated to be either a tumor suppressor or promoter depending on the cell type, and hypermethylation of the FBLN-3 promoter is often associated with human disease, especially cancer. We report that the promoter region of the FBLN-3 was significantly methylated (>95%) in some pancreatic cancer cell lines and thus FBLN-3 was poorly expressed in pancreatic cancer cell lines such as AsPC-1 and MiaPaCa-2. FBLN-3 overexpression significantly down-regulated the cellular level of c-MET and inhibited hepatocyte growth factor-induced c-MET activation, which were closely associated with γ-radiation resistance of cancer cells. Moreover, we also showed that c-MET suppression or inactivation decreased the cellular level of ALDH1 isozymes (ALDH1A1 or ALDH1A3), which serve as cancer stem cell markers, and subsequently induced inhibition of cell growth in pancreatic cancer cells. Therefore, forced overexpression of FBLN-3 sensitized cells to cytotoxic agents such as γ-radiation and strongly inhibited the stemness and epithelial to mesenchymal transition (EMT) property of pancreatic cancer cells. On the other hand, if FBLN3 was suppressed in FBLN-3-expressing BxPC3 cells, the results were opposite. This study provides the first demonstration that the FBLN-3/c-MET/ALDH1 axis in pancreatic cancer cells partially modulates stemness and EMT as well as sensitization of cells to the detrimental effects of γ-radiation.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2015

YB-1 overexpression promotes a TGF-β1-induced epithelial–mesenchymal transition via Akt activation

The Y-box binding protein-1 (YB-1) is a transcription/translation regulatory protein, and the expression thereof is associated with cancer aggressiveness. In the present study, we explored the regulatory effects of YB-1 during the transforming growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in lung adenocarcinoma cells. Downregulation of YB-1 increased E-cadherin promoter activity, and upregulation of YB-1 decreased promoter activity, suggesting that the YB-1 level may be correlated with the EMT. TGF-β1 induced YB-1 expression, and TGF-β1 translocated cytosolic YB-1 into the nucleus. YB-1 overexpression promoted TGF-β1-induced downregulation of epithelial markers, upregulation of mesenchymal markers, and cell migration. Moreover, YB-1 overexpression enhanced the expression of E-cadherin transcriptional repressors via TGF-β1-induced Akt activation. Our findings afford new insights into the role played by YB-1 in the TGF-β1 signaling pathway. - Highlights: • YB-1 regulates E-cadherin expression in A549 cells. • TGF-β1 induces upregulating and nuclear localization of YB-1. • YB-1 overexpression accelerates TGF-β1-induced EMT and cell migration. • YB-1 regulates Snail and Slug expression via Akt activation.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

Down-regulation of Transducin-Like Enhancer of Split protein 4 in hepatocellular carcinoma promotes cell proliferation and epithelial-Mesenchymal-Transition

Background: Transducin-Like Enhancer of Split protein 4 (TLE4) has been reported to be involved in some subsets of acute myeloid leukemia and colorectal cancer. In the present study, we aimed to explore the role of TLE4 in tumorigenesis and cancer progression in hepatocellular carcinoma (HCC). Methods: The expression pattern of TLE4 in HCC was determined by Western-blot and qRT-PCR, gain-of-function and loss-of-function was used to explore the biological role of TLE4 in HCC cells. A xenograft model was established to confirm its effects on proliferation. Results: The protein expression levels of TLE4 were significantly down-regulated in HCC tissues compared to matched adjacent normal liver tissues. In vitro, down-regulation of TLE4 in Huh7 or SMMC-7721 promoted cell proliferation and ectopical expression of TLE4 in Hep3B or Bel-7404 suppressed cell proliferation. In addition, the cell colony formation ability was enhanced after down-regulation of TLE4 expression in Huh-7 but suppressed after over-expression in Hep3B. Furthermore, down-regulation of TLE4 increased the cell invasion ability, as well as increased the expression level of Vimentin and decreased that of E-cadherin, indicating a phenotype of epithelial-mesenchymal transition (EMT) in HCC cells. On the contrary, ectopical expression of TLE4 in HCC cells decreased the cell invasion ability and inhibited EMT. In vivo, compared to control group, xenograft tumor volumes were significantly decreased in TLE4 overexpression group. Conclusions: These results demonstrated that TLE4 might play important regulatory roles in cellular proliferation and EMT process in HCC. - Highlights: • TLE4 is significantly down-regulated in HCC samples. • Down regulated of TLE4 in HCC cells promotes cell proliferation. • Down regulated of TLE4 in HCC cells promotes epithelial-to-mesenchymal transition.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer

Docetaxel efficiency in the therapy of prostate cancer (PCa) patients is limited due to the development of chemoresistance. Recent studies have implied a role of INPP4B in tumor chemoresistance, while the effects of INPP4B on docetaxel resistance in PCa have not been elucidated. In the present study, the docetaxel-resistant human PCa cell lines PC3-DR and DU-145-DR were established from the parental cell lines PC3 and DU-145, and the expression and role of INPP4B in docetaxel-resistant PCa cells were investigated. The results demonstrated that INPP4B expression was significantly downregulated in docetaxel-resistant cells. Overexpression of INPP4B increased the sensitivity to docetaxel and promoted cell apoptosis in PC3-DR and DU-145-DR cells. In addition, INPP4B overexpression downregulated the expression of the mesenchymal markers fibronectin, N-cadherin, and vimentin, and upregulated the expression level of the epithelial maker E-cadherin. Furthermore, INPP4B overexpression markedly inhibited the PI3K/Akt pathway. We also found that IGF-1, the inhibitor of PI3K/Akt, markedly blocked the change in EMT markers induced by overexpression of INPP4B, and reversed the resistance of PC3-DR and DU-145-DR cells to docetaxel, which is sensitized by Flag-INPP4B. In summary, the presented data indicate that INPP4B is crucial for docetaxel-resistant PCa cell survival, potentially by regulating EMT through the PI3K/Akt signaling pathway. - Highlights: • INPP4B is downregulated in docetaxel-resistant PCa cells. • INPP4B inhibits cell proliferation. • INPP4B induces cell apoptosis. • INPP4B inhibits PCa cell EMT.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5

Epithelial–mesenchymal transition (EMT) plays a pivotal role in the development of cancer. Has-miR-200b-3p is generally recognized as one of the fundamental regulators of EMT. In this study, we found that the expression of miR-200b-3p was downregulated in glioma tissues and human glioma cells U87 and U251. Meanwhile, Up-regulating miR-200b-3p enhanced E-cadherin, reduced mesenchymal markers, and decreased cell proliferation, migration, and invasion in vitro. In vivo, the xenograft mouse model also unveiled the suppressive effects of miR-200b-3p on tumor growth. Additionally, The extracellular-regulated protein kinase 5 (ERK5) was confirmed as a direct target gene of miR-200b-3p. The direct suppression of ERK5 expressions by miR-200b-3p was revealed by luciferase reporter assay, quantitative RT-PCR analysis, and western blot. Moreover, we observed an inverse correlation between miR-200b-3p and ERK5 in human glioma tissues. In summary, our findings demonstrated that miR-200b-3p suppresses glioma tumor growth, invasion, and reverses EMT through downregulated its target ERK5.

60 APPLIED LIFE SCIENCES↗